“It’s exciting to see the growing real-world evidence showing how AI-enhanced ECG analysis can play a pivotal role in identifying new patients with hypertrophic cardiomyopathy,” said Milind ...
Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...
Background Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) often experience worsening cardiac disease (WCD) ...
Real-world evidence to be presented at the American College of Cardiology Scientific Session 2025 demonstrates positive impact of Viz.ai on disease detection and care coordination SAN FRANCISCO ...